Challenge: Manus Neurodynamica has developed a novel pen and software that improves the diagnosis of Parkinson’s Disease. The company is considering ways to fund their journey of bringing the medical device to market.
Background: The Innovation SuperNetwork was contacted to support an application to the Innovate UK SBRI GPs of the future funding call. The call was looking for devices that would save valuable GP time in an over-stretched NHS service and improve diagnosis and treatment of progressive illnesses like Parkinson’s. With the potential to reduce referral rates to consultants, decrease patient anxiety and enable better treatment, we were confident Manus Neurodynamica’s device and technology solution met the funding criteria.
Results: The submission was successful and the company was invited to pitch followed by an interview. The team secured a portion of the £2.1 million funding call. This investment will significantly accelerate the adoption of this technology by the NHS and, ultimately, change patients’ lives.
“In my view, the kind of professional support that you provide at no cost to companies is just gold dust.” Rutger Zietsma, Manus Neurodynamica